Clal Biotechnology Industries Ltd (CBI) — Financial Flexibility Index
Clal Biotechnology Industries Ltd (CBI) has a Financial Flexibility Index of -0.05x as of June 2025. Free cash flow of ILA-1.06 Million (operating CF ILA-1.06 Million minus capex ILA0.00) represents 0% of total liabilities (ILA19.52 Million). Check Clal Biotechnology Industries Ltd (CBI) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Clal Biotechnology Industries Ltd Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Clal Biotechnology Industries Ltd across 19 annual periods. See CBI net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Clal Biotechnology Industries Ltd (2006–2024)
Year-by-year free cash flow to debt coverage for Clal Biotechnology Industries Ltd. For the full company profile including market capitalisation, see CBI market cap overview.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.30x | ILA-6.48 Million | ILA-6.48 Million | ILA21.52 Million | ▼ -30.8% |
| 2023 | -0.23x | ILA-8.51 Million | ILA-8.51 Million | ILA36.98 Million | ▲ +84.9% |
| 2022 | -1.53x | ILA-57.76 Million | ILA-59.04 Million | ILA37.79 Million | ▼ -309.9% |
| 2021 | -0.37x | ILA-39.73 Million | ILA-41.33 Million | ILA106.55 Million | ▼ -24.4% |
| 2020 | -0.30x | ILA-30.04 Million | ILA-33.23 Million | ILA100.24 Million | ▼ -219.6% |
| 2019 | 0.25x | ILA29.86 Million | ILA27.03 Million | ILA119.12 Million | ▲ +144.3% |
| 2018 | -0.57x | ILA-84.03 Million | ILA-86.98 Million | ILA148.46 Million | ▼ -47.6% |
| 2017 | -0.38x | ILA-86.72 Million | ILA-91.41 Million | ILA226.14 Million | ▼ -30.5% |
| 2016 | -0.29x | ILA-107.65 Million | ILA-112.63 Million | ILA366.21 Million | ▲ +4.8% |
| 2015 | -0.31x | ILA-135.94 Million | ILA-147.00 Million | ILA440.31 Million | ▼ -15.9% |
| 2014 | -0.27x | ILA-114.14 Million | ILA-115.95 Million | ILA428.44 Million | ▲ +2.2% |
| 2013 | -0.27x | ILA-147.25 Million | ILA-148.98 Million | ILA540.45 Million | ▼ -21.8% |
| 2012 | -0.22x | ILA-79.22 Million | ILA-81.22 Million | ILA354.19 Million | ▲ +68.8% |
| 2011 | -0.72x | ILA-101.82 Million | ILA-102.45 Million | ILA142.01 Million | ▲ +7.4% |
| 2010 | -0.77x | ILA-107.00 Million | ILA-111.93 Million | ILA138.20 Million | ▼ -54.0% |
| 2009 | -0.50x | ILA-77.13 Million | ILA-86.86 Million | ILA153.41 Million | ▼ -49.3% |
| 2008 | -0.34x | ILA-50.99 Million | ILA-52.41 Million | ILA151.47 Million | ▲ +17.8% |
| 2007 | -0.41x | ILA-45.45 Million | ILA-47.05 Million | ILA110.98 Million | ▲ +77.4% |
| 2006 | -1.81x | ILA-22.67 Million | ILA-23.55 Million | ILA12.50 Million | — |